The Daily Ledger

StartupsNews

Oura to buy AI primary-care firm Counsel Health for $625M

Smart ring maker Oura said it will acquire Counsel Health, an AI-native primary care company, for $625 million, weeks after shelving its IPO.

The Daily Ledger Staff · Updated 3 min read

Oura, the maker of the popular smart ring, announced on Tuesday, November 10, 2026, that it will acquire Counsel Health, an AI-native primary care company, for $625 million. The deal is expected to close before the end of 2027, according to TechCrunch's report.

What Counsel Health does

Counsel Health runs an AI-powered healthcare platform that pairs a chat-based medical experience with licensed physicians. Its service was integrated into the Oura app in June. Users can receive personalized medical advice from Counsel's medical AI and can chat with a physician when needed. The two companies say they plan to widen their partnership across preventative care, acute care, and specialty and chronic care.

Counsel raised a $25 million Series A a year ago in a round led by Andreessen Horowitz and GV. PitchBook estimates its total funding at $36 million. After the acquisition, Counsel will continue serving its existing and new enterprise partners, and it aims to bring its AI-native care model to more people beyond Oura members.

People involved

Oura CEO Tom Hale said the company helps members "understand their physiology," and that Counsel adds the ability to act on health needs, from prescriptions to referrals. Counsel CEO Muthu Alagappan will join Oura as chief clinical AI officer. Bloomberg reports that Counsel's 70 employees will also move to Oura. Alagappan said Counsel has built its medical AI around "trust, safety and responsibility," and added that Oura's data gives clinicians "objective context."

Oura's position

The announcement arrives a few weeks after Oura indefinitely postponed an initial public offering that could have been worth up to $2.2 billion, citing "uncertainty in the IPO market." The company has dominated the smart ring category but faces competition from rivals such as RingConn and Ultrahuman.

Oura's business has been growing quickly. Revenue rose 153% year over year to $533 million for the quarter ended September 30, and revenue for fiscal year 2026 is roughly $1.75 billion, up 92% from a year earlier. The company reached an $11 billion valuation after a $900 million late-stage funding round in October 2025.

Why it matters

The acquisition signals a push by wearable makers to move beyond tracking data and into delivering care. By combining continuous body measurements from its rings with a physician-backed AI service, Oura is betting that members will want help acting on what their devices show them. Whether that approach can scale, and how regulators and patients respond to AI-led primary care, will become clearer once the deal closes and the combined service expands beyond its current user base.

For now, the transaction gives Oura a clinical team, a medical AI product and an experienced founder-CEO in a leadership role, while giving Counsel access to a large base of consumers who already use a health-focused device every day.

Sources

Written with automated tools from the sources above and published without editor review. Spotted an error? Tell us · Corrections Policy

Report a problem with this story · Copyright & takedown